Zetz v. Boston Scientific Corporation

District Court, E.D. California·Decided March 1, 2022·No. 1:19-cv-00451·Unknown

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF CALIFORNIA

AUTUMN ZETZ, et al., Case No. 1:19-cv-00451-AWI-SAB

Plaintiffs, ORDER DENYING PLAINTIFF’S MOTION TO QUASH SUBPOENA OF NON-PARTY v. GREG VIGNA OR ALTERNATIVELY MOTION FOR PROTECTIVE ORDER (ECF No. 75) Defendant.

I. Currently before the Court is Plaintiffs Autumn Zetz (“Zetz”) and Eric Zetz’s (collectively “Plaintiffs”) motion to quash or alternatively impose a protective order regarding the notice of deposition and subpoena to testify at a deposition in a civil action for nonparty Greg Vigna (“Vigna”) served by Defendant Boston Scientific Corporation (“Defendant”). The Court heard oral argument on the motion to quash on February 23, 2022 via Zoom videoconference. Counsel Lourdes DeArmas of the Dolan Law Firm appeared by videoconference for Plaintiffs. Counsel Karen Firstenberg of Faegre Drinker Biddle Reath LLP appeared by videoconference for Defendant. Vigna did not appear. Having considered the moving and opposition papers, arguments presented at the February 23, 2022 hearing, as well as the Court’s file, the Court issues the following order denying Plaintiffs’ motion to quash the deposition subpoena. II. Plaintiff Autumn Zetz was implanted with the Obtryx sling (“device”), a pelvic mesh insert used to repair abdominal hernias, prolapsed organs, pelvic organ prolapse and stress urinary incontinence, on November 12, 2008. (ECF No. 1-1.) Zetz was implanted with the device to treat stress urinary incontinence. The device was designed, manufactured, packaged, labeled, distributed, and sold by Defendant. Plaintiffs contend Defendant was aware of defects inherent in the device but deliberately concealed them and instead represented the device was safe and effective and continued to market the device to physicians and patients, including Plaintiffs, without adequate warnings. Plaintiffs further contend the device was correctly implanted in Zetz but degraded on explant and caused multiple medical conditions in Zetz, including pudendal neuralgia, catastrophic pain syndrome, bowel and bladder dysfunction, dyspareunia, and loss of mobility. As a result, Plaintiffs claim Zetz suffered significant mental and physical pain and suffering, permanent injury, continued medical treatment and procedures, and financial or economic loss. Zetz’s husband additionally asserts a loss of consortium claim. Plaintiffs initiated this lawsuit on February 1, 2019 in the Fresno Superior Court, asserting claims for strict liability, negligence, breach of implied and express warranty, fraud, negligent misrepresentation, fraud by concealment, and loss of consortium. (Id.) Defendant removed the action to federal court on April 12, 2019. (ECF No. 1.) On May 16, 2019, the Court related the instant action and cases 1:19-cv-00381-DAD-SKO; 1:19-cv-00575-LJO-SKO; 1:19-cv-00576- AWI-EPG; 1:19-cv-00578-DAD-SKO; 1:19-cv-00581-DAD-SKO; 1:19-cv-00583-DAD-EPG; 1:19-cv-00584-LJO-SAB; 1:19-cv-00585-LJO-EPG; 1:19-cv-00587-DAD-BAM; 1:19-cv-00588- LJO-BAM; 2:19-cv-00773-MCE-EFB with Case No. 1:19-cv-00574-LJO-SAB, based on the finding that the actions involve the same parties, are based on similar claims, and present similar questions of fact and law. (ECF No. 8.) On February 1, 2019, Plaintiffs filed the operative first amended complaint. (ECF No. 16; see also ECF No. 75-1 at 1.) On October 11, 2019, the parties appeared for the initial scheduling conference. (ECF No. 26.) Thereafter, the Court issued the initial scheduling order. (ECF No. 27; see also ECF No. 30 (corrected order).) Since that date, the parties have submitted, and the Court has granted, seven stipulated requests to modify the schedule. (ECF Nos. 40, 41, 42, 43, 47, 48, 52, 55, 58, 59, 66, 67, 68, 69.) Pursuant to the current schedule, expert and non-expert discovery closed on January 21, 2022; the dispositive motion filing deadline is March 25, 2022; the pretrial conference is set for August 3, 2022; and trial is set to commence on October 4, 2022. (ECF No. 69.) A stipulated protective order governing the production of confidential documents was entered in this case on June 23, 2020. (ECF No. 46.) On January 21, 2022, Plaintiffs filed the instant motion to quash deposition of non-party Greg Vigna or alternatively motion for protective order. (ECF No. 75.) Plaintiffs seek to quash Vigna’s deposition on the basis that Plaintiffs retained Vigna and his law firm during the pre- litigation phase of this action on August 21, 2018, and that all communications between Plaintiffs and Vigna are protected by the attorney-client privilege. Alternatively, Plaintiffs move for a protective order to protect their right to confidentiality of communications with Vigna. On January 24, 2022, the Court ordered the parties to file a joint statement in compliance with Local Rule 251. (ECF No. 77.) Instead, on February 9, 2022, Defendant filed an opposition to the motion. (ECF No. 78.) However, on February 16, 2022, the parties filed a joint statement. (ECF No. 79.) On February 23, 2022, the Court heard oral argument on Plaintiffs’ motion to quash via Zoom videoconference. Rule 45 of the Federal Rules of Civil Procedure authorizes the issuance of a subpoena to command a nonparty to “produce designated documents, electronically stored information, or tangible things in that person’s possession, custody, or control. . . .” Fed. R. Civ. P. 45(a)(1)(A)(iii). In response to the subpoena, the nonparty must serve objections to the request before the earlier of the time specified for compliance or fourteen days after the subpoena is served. Fed. R. Civ. P. 45(d)(2)(B.) If an objection is made, the serving party may move for an order compelling compliance in the court for the district where compliance is required. Fed. R. Civ. P. 45(b)(1)(B(i). It is well settled that the scope of discovery under a subpoena is the same as the scope of discovery under Rule 26(b) and 34. Goodyear Tire & Rubber Co. v. Kirk’s Tire & Auto Service Ctr., 211 F.R.D. 648, 662 (D. Kan. 2003) (quoting Advisory Committee Note to the 1970 Amendment of Rule 45(d)(1) that the amendments “make it clear that the scope of discovery through a subpoena is the same as that applicable to Rule 34 and the other discovery rules.”). Rule 34(a) provides that a party may serve a request that is within the scope of Rule 26. Under the Federal Rule of Civil Procedure 26: Parties may obtain discovery regarding any nonprivileged matter that is relevant to any party’s claim or defense and proportional to the needs of the case, considering the importance of the issues at stake in the action, the amount in controversy, the parties’ relative access to relevant information, the parties’ resources, the importance of the discovery in resolving the issues, and whether the burden or expense of the proposed discovery outweighs its likely benefit. Information within this scope of discovery need not be admissible in evidence to be discoverable. Fed. R. Civ. P. 26(b)(1). Relevancy is broadly defined to encompass any matter that bears on, or that reasonably could lead to other matter that could bear on, any issue that is or may be in the case. Oppenheimer Fund, Inc. v. Sanders, 437 U.S. 34

Free access — add to your briefcase to read the full text and ask questions with AI

Zetz v. Boston Scientific Corporation, (E.D. Cal. 2022).

Zetz v. Boston Scientific Corporation (Zetz v. Boston Scientific Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Oppenheimer Fund, Inc. v. Sanders
437 U.S. 340 (Supreme Court, 1978)
Upjohn Co. v. United States
449 U.S. 383 (Supreme Court, 1981)
Buck Wilcoxon v. United States
231 F.2d 384 (Tenth Circuit, 1956)
United States v. Jesse Ray Pipkins
528 F.2d 559 (Fifth Circuit, 1976)
United States v. James Martorano
557 F.2d 1 (First Circuit, 1977)
United States v. Richard William Landof
591 F.2d 36 (Ninth Circuit, 1979)
United States v. Richard W. Miller
874 F.2d 1255 (Ninth Circuit, 1989)
Danielle J. Pittsley v. Sergeant Philip Warish
927 F.2d 3 (First Circuit, 1991)
United States v. John P. Moscony
927 F.2d 742 (Third Circuit, 1991)
United States v. Eugene Donald Schaltenbrand
930 F.2d 1554 (Eleventh Circuit, 1991)
Phillips v. General Motors Corporation
307 F.3d 1206 (Ninth Circuit, 2002)